BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37534622)

  • 1. Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection.
    Zhang L; Li YH; Kibler K; Kraberger S; Varsani A; Turk J; Elmadbouly N; Aliskevich E; Spaccarelli L; Estifanos B; Enow J; Zanetti IR; Saldevar N; Lim E; Schlievert J; Browder K; Wilson A; Juan FA; Pinteric A; Garg A; Monder H; Saju R; Gisriel S; Jacobs B; Karr TL; Florsheim EB; Kumar V; Wallen J; Rahman M; McFadden G; Hogue BG; Lucas AR
    EMBO Mol Med; 2023 Sep; 15(9):e17376. PubMed ID: 37534622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serpins, the vasculature, and viral therapeutics.
    Richardson J; Viswanathan K; Lucas A
    Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.
    Chen H; Zheng D; Abbott J; Liu L; Bartee MY; Long M; Davids J; Williams J; Feldmann H; Strong J; Grau KR; Tibbetts S; Macaulay C; McFadden G; Thoburn R; Lomas DA; Spinale FG; Virgin HW; Lucas A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4114-27. PubMed ID: 23774438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.
    Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR
    Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses.
    Dai E; Viswanathan K; Sun YM; Li X; Liu LY; Togonu-Bickersteth B; Richardson J; Macaulay C; Nash P; Turner P; Nazarian SH; Moyer R; McFadden G; Lucas AR
    J Biol Chem; 2006 Mar; 281(12):8041-50. PubMed ID: 16407226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion.
    Guo Q; Yaron JR; Wallen JW; Browder KF; Boyd R; Olson TL; Burgin M; Ulrich P; Aliskevich E; Schutz LN; Fromme P; Zhang L; Lucas AR
    Front Cardiovasc Med; 2021; 8():633212. PubMed ID: 33665212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins).
    Yaron JR; Zhang L; Burgin M; Schutz LN; Awo EA; Keinan S; McFadden G; Ambadapadi S; Guo Q; Chen H; Lucas AR
    Methods Mol Biol; 2021; 2225():107-123. PubMed ID: 33108660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral serpin therapeutics from concept to clinic.
    Chen H; Zheng D; Davids J; Bartee MY; Dai E; Liu L; Petrov L; Macaulay C; Thoburn R; Sobel E; Moyer R; McFadden G; Lucas A
    Methods Enzymol; 2011; 499():301-29. PubMed ID: 21683260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury.
    Dai E; Guan H; Liu L; Little S; McFadden G; Vaziri S; Cao H; Ivanova IA; Bocksch L; Lucas A
    J Biol Chem; 2003 May; 278(20):18563-72. PubMed ID: 12637546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets.
    Munuswamy-Ramanujam G; Dai E; Liu L; Shnabel M; Sun YM; Bartee M; Lomas DA; Lucas AR
    Thromb Haemost; 2010 Mar; 103(3):545-55. PubMed ID: 20135065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.
    Viswanathan K; Richardson J; Togonu-Bickersteth B; Dai E; Liu L; Vatsya P; Sun YM; Yu J; Munuswamy-Ramanujam G; Baker H; Lucas AR
    J Leukoc Biol; 2009 Mar; 85(3):418-26. PubMed ID: 19052145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.
    Jairajpuri MA; Ansari S
    Clin Sci (Lond); 2020 Sep; 134(17):2235-2241. PubMed ID: 32869854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.
    Viswanathan K; Bot I; Liu L; Dai E; Turner PC; Togonu-Bickersteth B; Richardson J; Davids JA; Williams JM; Bartee MY; Chen H; van Berkel TJ; Biessen EA; Moyer RW; Lucas AR
    PLoS One; 2012; 7(9):e44694. PubMed ID: 23049756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
    Rosendal E; Mihai IS; Becker M; Das D; Frängsmyr L; Persson BD; Rankin GD; Gröning R; Trygg J; Forsell M; Ankarklev J; Blomberg A; Henriksson J; Överby AK; Lenman A
    mBio; 2022 Jun; 13(3):e0089222. PubMed ID: 35532162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities.
    Ambadapadi S; Munuswamy-Ramanujam G; Zheng D; Sullivan C; Dai E; Morshed S; McFadden B; Feldman E; Pinard M; McKenna R; Tibbetts S; Lucas A
    J Biol Chem; 2016 Feb; 291(6):2874-87. PubMed ID: 26620556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal Structure of Cleaved Serp-1, a Myxomavirus-Derived Immune Modulating Serpin: Structural Design of Serpin Reactive Center Loop Peptides with Improved Therapeutic Function.
    Mahon BP; Ambadapadi S; Yaron JR; Lomelino CL; Pinard MA; Keinan S; Kurnikov I; Macaulay C; Zhang L; Reeves W; McFadden G; Tibbetts S; McKenna R; Lucas AR
    Biochemistry; 2018 Feb; 57(7):1096-1107. PubMed ID: 29227673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity.
    Li X; Schneider H; Peters A; Macaulay C; King E; Sun Y; Liu L; Dai E; Davids JA; McFadden G; Lucas A
    Open Biochem J; 2008; 2():6-15. PubMed ID: 18949070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing.
    Johansen MD; Mahbub RM; Idrees S; Nguyen DH; Miemczyk S; Pathinayake P; Nichol K; Hansbro NG; Gearing LJ; Hertzog PJ; Gallego-Ortega D; Britton WJ; Saunders BM; Wark PA; Faiz A; Hansbro PM
    Am J Respir Crit Care Med; 2022 Sep; 206(6):712-729. PubMed ID: 35549656
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase.
    Nash P; Barry M; Seet BT; Veugelers K; Hota S; Heger J; Hodgkinson C; Graham K; Jackson RJ; McFadden G
    Biochem J; 2000 Apr; 347(Pt 2):375-82. PubMed ID: 10749666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.